OKEOMA CHUKWU: Open Payments
NPI 1043716137 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 38 payments from 9 companies in 2025. Trend: 2023 $640 · 2024 $1,607 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $198 |
| Lundbeck LLC | 4 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $95 |
| Alkermes, Inc. | 4 | $87 |
| Axsome Therapeutics, Inc. | 5 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 1 | $32 |
Products named: INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, Auvelity, COBENFY, ARISTADA, INVEGA SUSTENNA, VIVITROL.
Industry payments across GA — which companies pay providers there.
